Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Conestoga Small Cap Composite Joe Monahan | “KIDS is the first company to focus solely on orthopedic care for the pediatric market. After being a leader in 1Q, KIDS drifted modestly lower during 2Q. KIDS reported revenue growth for 1Q ahead of street expectations. The company also raised full-year revenue guidance. However, EBITDA margins came in weaker-than-expected for 1Q due to the timing of some expenses and slightly higher SG&A. Management reiterated their EBITDA guidance for the year. BSD Analysis: OrthoPediatrics is a unique pediatric orthopedic monopoly, capitalizing on the extreme barriers to entry and non-cyclical demand inherent in the children's surgical device market. The investment is built on the company's commitment to designing anatomically appropriate implants for a patient population that traditional orthopedic giants ignore, creating a fierce competitive moat. Its consistent, double-digit revenue growth is driven by market share gains and the expansion of its comprehensive product suite across trauma, deformity, and scoliosis. KIDS is a high-growth, pure-play bet on a structurally stable, high-margin niche, with the eventual payoff coming through accelerating profitability as its immense revenue scale is achieved.” | BULL | Q2 2025 Jun 30, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
